Nan van Geloven
Nan van Geloven
Assistant professor biostatistics, Leiden University medical center
Verified email at lumc.nl
Title
Cited by
Cited by
Year
Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
K Boonstra, RK Weersma, KJ van Erpecum, EA Rauws, BWM Spanier, ...
Hepatology 58 (6), 2045-2055, 2013
4442013
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
IN van Schaik, V Bril, N van Geloven, HP Hartung, RA Lewis, G Sobue, ...
The Lancet Neurology 17 (1), 35-46, 2018
1732018
Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in Brugada syndrome: a study of electrocardiograms …
PG Postema, PFHM van Dessel, JA Kors, AC Linnenbank, G van Herpen, ...
Journal of the American College of Cardiology 55 (8), 789-797, 2010
1532010
Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient data
SM Zinkstok, MDI Vergouwen, ST Engelter, PA Lyrer, LH Bonati, M Arnold, ...
Stroke 42 (9), 2515-2520, 2011
1512011
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4‐associated cholangitis from primary sclerosing cholangitis
K Boonstra, EL Culver, LM de Buy Wenniger, MJ van Heerde, ...
Hepatology 59 (5), 1954-1963, 2014
1442014
Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a …
MAM Beijk, M Klomp, NJW Verouden, N van Geloven, KT Koch, ...
European heart journal 31 (9), 1055-1064, 2010
1312010
Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: Disease penetrance and expression in cardiac ryanodine receptor mutation–carrying relatives
C van der Werf, I Nederend, N Hofman, N van Geloven, C Ebink, ...
Circulation: Arrhythmia and Electrophysiology 5 (4), 748-756, 2012
1302012
Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment …
P Damman, MAM Beijk, WJ Kuijt, NJW Verouden, N van Geloven, ...
Journal of the American College of Cardiology 57 (1), 29-36, 2011
1122011
Oil-based or water-based contrast for hysterosalpingography in infertile women
K Dreyer, J Van Rijswijk, V Mijatovic, M Goddijn, HR Verhoeve, ...
New England Journal of Medicine 376 (21), 2043-2052, 2017
1092017
Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi
T Israëls, MD van de Wetering, P Hesseling, N van Geloven, HN Caron, ...
Pediatric blood & cancer 53 (1), 47-52, 2009
1062009
Neurocognitive deficits in children with sickle cell disease: a comprehensive profile
CT Hijmans, K Fijnvandraat, MA Grootenhuis, N van Geloven, H Heijboer, ...
Pediatric blood & cancer 56 (5), 783-788, 2011
952011
Are patient characteristics associated with the accuracy of hysterosalpingography in diagnosing tubal pathology? An individual patient data meta-analysis
KA Broeze, BC Opmeer, N Van Geloven, S Coppus, JA Collins, ...
Human reproduction update 17 (3), 293-300, 2011
942011
The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI …
WJ Kikkert, N van Geloven, MH van der Laan, MM Vis, J Baan, KT Koch, ...
Journal of the American College of Cardiology 63 (18), 1866-1875, 2014
892014
Prognostic factors of motor impairment, disability, and quality of life in newly diagnosed PD
DC Velseboer, M Broeders, B Post, N van Geloven, JD Speelman, ...
Neurology 80 (7), 627-633, 2013
842013
Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease
B Post, D Muslimovic, N van Geloven, JD Speelman, B Schmand, ...
Movement Disorders 26 (3), 449-456, 2011
832011
Aspirin in Alzheimer’s disease: increased risk of intracerebral hemorrhage: cause for concern?
H Thoonsen, E Richard, P Bentham, R Gray, N van Geloven, RJ De Haan, ...
Stroke 41 (11), 2690-2692, 2010
702010
1-Year Outcome of TRIAS HR (TRI-Stent Adjudication Study–High Risk of Restenosis) A Multicenter, Randomized Trial Comparing Genous Endothelial Progenitor Cell Capturing Stents …
M Klomp, MA Beijk, C Varma, JJ Koolen, E Teiger, G Richardt, F Bea, ...
JACC: Cardiovascular Interventions 4 (8), 896-904, 2011
532011
Chlamydia antibody testing and diagnosing tubal pathology in subfertile women: an individual patient data meta-analysis
KA Broeze, BC Opmeer, S Coppus, N Van Geloven, MFC Alves, ...
Human reproduction update 17 (3), 301-310, 2011
532011
Timing of angiography with a routine invasive strategy and long-term outcomes in non–ST-segment elevation acute coronary syndrome: a collaborative analysis of individual …
P Damman, N van Geloven, L Wallentin, B Lagerqvist, KAA Fox, T Clayton, ...
JACC: Cardiovascular Interventions 5 (2), 191-199, 2012
452012
Two‐year follow‐up of the genous™ endothelial progenitor cell capturing stent versus the taxus liberté stent in patients with De Novo coronary artery lesions with a …
MAM Beijk, M Klomp, N van Geloven, KT Koch, JPS Henriques, J Baan, ...
Catheterization and Cardiovascular Interventions 78 (2), 189-195, 2011
442011
The system can't perform the operation now. Try again later.
Articles 1–20